FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Steven Yancey

Research Profile

Chemicals & Drugs

Disorders

Asthma

Procedures

Phenomena

Forced Expiratory Volume

Concepts & Ideas

Co-author Network

Publications

TOP 3
Rohit K Katial; John J Oppenheimer; Nancy K Ostrom; Giselle S Mosnaim; Steven W Yancey; Kelli R Waitkus-Edwards; Barbara A Prillaman; Hector G Ortega
Adding montelukast to fluticasone propionate/salmeterol for control of asthma and seasonal allergic rhinitis.
Eugene R Bleecker; Steven W Yancey; Leslie A Baitinger; Lisa D Edwards; Michael Klotsman; Wayne H Anderson; Paul Dorinsky
Salmeterol response is not affected by beta2-adrenergic receptor genotype in subjects with persistent asthma.
Nizar N Jarjour; Susan J Wilson; Steven M Koenig; Michel Laviolette; Wendy C Moore; William B Davis; Dennis E Doherty; Qutayba Hamid; Elliott Israel; mani kavuru; Joe W Ramsdell; Donald P Tashkin; Donna S Reilly; Steven W Yancey; Lisa D Edwards; John L Stauffer; Paul Dorinsky; Ratko Djukanovic
Control of airway inflammation maintained at a lower steroid dose with 100/50 microg of fluticasone propionate/salmeterol.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Steven Yancey (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: Rohit K Katial; John J Oppenheimer; Nancy K Ostrom; Giselle S Mosnaim; Steven W Yancey; Kelli R Waitkus-Edwards; Barbara A Prillaman; Hector G Ortega
Adding montelukast to fluticasone propionate/salmeterol for control of asthma and seasonal allergic rhinitis.
Allergy and asthma proceedings : the official journal of regional and state allergy societies 2010;31(1):68-75.
2006: Eugene R Bleecker; Steven W Yancey; Leslie A Baitinger; Lisa D Edwards; Michael Klotsman; Wayne H Anderson; Paul Dorinsky
Salmeterol response is not affected by beta2-adrenergic receptor genotype in subjects with persistent asthma.
The Journal of allergy and clinical immunology 2006;118(4):809-16.
2006: Nizar N Jarjour; Susan J Wilson; Steven M Koenig; Michel Laviolette; Wendy C Moore; William B Davis; Dennis E Doherty; Qutayba Hamid; Elliott Israel; mani kavuru; Joe W Ramsdell; Donald P Tashkin; Donna S Reilly; Steven W Yancey; Lisa D Edwards; John L Stauffer; Paul Dorinsky; Ratko Djukanovic
Control of airway inflammation maintained at a lower steroid dose with 100/50 microg of fluticasone propionate/salmeterol.
The Journal of allergy and clinical immunology 2006;118(1):44-52.
2006: Harold S Nelson; Scott Weiss; Eugene R Bleecker; Steven W Yancey; Paul Dorinsky
The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol.
Chest 2006;129(1):15-26.
2005: Robert A Nathan; Steven W Yancey; Kelli Waitkus-Edwards; Barbara A Prillaman; John L Stauffer; Edward E Philpot; Paul Dorinsky; Harold S Nelson
Fluticasone propionate nasal spray is superior to montelukast for allergic rhinitis while neither affects overall asthma control.
Chest 2005;128(4):1910-20.
2004: Richard D O'Connor; Richard H Stanford; Courtney Crim; Steven W Yancey; Lisa Edwards; Kathleen A Rickard; Paul Dorinsky
Effect of fluticasone propionate and salmeterol in a single device, fluticasone propionate, and montelukast on overall asthma control, exacerbations, and costs.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2004;93(6):581-8.
2003: William W Busse; Steven M Koenig; John Oppenheimer; Steven A Sahn; Steven W Yancey; Donna Reilly; Lisa D Edwards; Paul Dorinsky
Steroid-sparing effects of fluticasone propionate 100 microg and salmeterol 50 microg administered twice daily in a single product in patients previously controlled with fluticasone propionate 250 microg administered twice daily.
The Journal of allergy and clinical immunology 2003;111(1):57-65.
2001: J E Fish; E Israel; John Joseph Murray; Amanda Emmett; R Boone; Steven W Yancey; Kathleen A Rickard
Salmeterol powder provides significantly better benefit than montelukast in asthmatic patients receiving concomitant inhaled corticosteroid therapy.
Chest 2001;120(2):423-30.
2001: Harold S Nelson; Robert A Nathan; Christopher Kalberg; Steven W Yancey; Kathleen A Rickard
Comparison of inhaled salmeterol and oral zafirlukast in asthmatic patients using concomitant inhaled corticosteroids.
MedGenMed : Medscape general medicine 2001;3(4):3.
2001: Paul Dorinsky; Lisa D Edwards; Steven W Yancey; Kathleen A Rickard
Use of changes in symptoms to predict changes in lung function in assessing the response to asthma therapy.
Clinical therapeutics 2001;23(5):701-14.
1999: Robert A Nathan; J L Pinnas; HJ Schwartz; J Grossman; Steven W Yancey; Amanda Emmett; Kathleen A Rickard
A six-month, placebo-controlled comparison of the safety and efficacy of salmeterol or beclomethasone for persistent asthma.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 1999;82(6):521-9.
1999: L Wiegand; C N Mende; G Zaidel; C W Zwillich; V J Petrocella; Steven W Yancey; Kathleen A Rickard
Salmeterol vs theophylline: sleep and efficacy outcomes in patients with nocturnal asthma.
Chest 1999;115(6):1525-32.
1999: William W Busse; H Nelson; J Wolfe; Christopher Kalberg; Steven W Yancey; Kathleen A Rickard
Comparison of inhaled salmeterol and oral zafirlukast in patients with asthma.
The Journal of allergy and clinical immunology 1999;103(6):1075-80.
1999: Harold S Nelson; R B Berkowitz; D A Tinkelman; Amanda Emmett; Kathleen A Rickard; Steven W Yancey
Lack of subsensitivity to albuterol after treatment with salmeterol in patients with asthma.
American journal of respiratory and critical care medicine 1999;159(5 Pt 1):1556-61.
1999: J J Condemi; S Goldstein; Christopher Kalberg; Steven W Yancey; Amanda Emmett; Kathleen A Rickard
The addition of salmeterol to fluticasone propionate versus increasing the dose of fluticasone propionate in patients with persistent asthma. Salmeterol Study Group.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 1999;82(4):383-9.
1999: Donald A Mahler; James F Donohue; R A Barbee; M D Goldman; N J Gross; M E Wisniewski; Steven W Yancey; B A Zakes; Kathleen A Rickard; Wayne H Anderson
Efficacy of salmeterol xinafoate in the treatment of COPD.
Chest 1999;115(4):957-65.
1998: A D Adinoff; HJ Schwartz; Kathleen A Rickard; Steven W Yancey; B E Swearingen
Salmeterol compared with current therapies in chronic asthma.
The Journal of family practice 1998;47(4):278-84.
1997: S J Pollard; S L Spector; Steven W Yancey; FM Cox; Amanda Emmett
Salmeterol versus theophylline in the treatment of asthma.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 1997;78(5):457-64.